Literature DB >> 19181441

Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.

Zhenbo Zhang1, Lin Jia, Youji Feng, Wenxin Zheng.   

Abstract

We previously showed that the expressing level of FSH receptor (FSHR) increased from ovarian epithelial inclusions (OEIs) to benign ovarian epithelial tumors (OETs) and to borderline OETs, whereas FSHR levels decreased with an increase in carcinoma grade. The aim of this study was to investigate the role of FSHR in OET development. MCV152 cells with FSHR overexpression showed an increased cellular proliferation and invasive capacity, which was associated with reduced levels of prohibitin and RII-beta expression and increased levels of HER-2/neu, c-Myc, and EGFR expression. Overexpression of FSHR may be associated with an elevated level of OET cell proliferation via an enhanced activity of potential oncogenic pathways. Therefore, the findings in this study suggest that overexpression of FSHR may play a role in OET development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181441     DOI: 10.1016/j.canlet.2008.12.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?

Authors:  Konstantinos Papadimitriou; Panteleimon Kountourakis; Anastasia E Kottorou; Anna G Antonacopoulou; Christian Rolfo; Marc Peeters; Haralabos P Kalofonos
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

2.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

3.  FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway.

Authors:  Suocheng Wei; Xiaoyun Shen; Luju Lai; Haoqin Liang; Yingying Deng; Zhuandi Gong; Tuanjie Che
Journal:  Oncotarget       Date:  2018-04-27

4.  Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.

Authors:  Ning Zhang; Junjun Qiu; Tingting Zheng; Xiaodan Zhang; Keqin Hua; Ying Zhang
Journal:  Oncol Rep       Date:  2017-12-15       Impact factor: 3.906

5.  Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer.

Authors:  Jun Zhou; Yiding Chen; Yiting Huang; Jinpei Long; Fang Wan; Suzhan Zhang
Journal:  Oncol Lett       Date:  2013-08-07       Impact factor: 2.967

6.  Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.

Authors:  Zhenbo Zhang; Yaping Zhu; Yunli Lai; Xiaomei Wu; Zhengzhong Feng; Yinhua Yu; Robert C Bast; Xiaoping Wan; Xiaowei Xi; Youji Feng
Journal:  Int J Oncol       Date:  2013-08-06       Impact factor: 5.650

7.  Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts.

Authors:  Chung-Wein Lee; Lili Guo; Daniela Matei; Keith Stantz
Journal:  J Biotechnol Biomater       Date:  2015-09-10

8.  An Investigation on a Novel Anti-tumor Fusion Peptide of FSH33-53-IIKK.

Authors:  Runlin Yang; Ping Liu; Donghui Pan; Pengjun Zhang; Zhicheng Bai; Yuping Xu; Lizhen Wang; Junjie Yan; Yongjun Yan; Xingdang Liu; Min Yang
Journal:  J Cancer       Date:  2016-05-24       Impact factor: 4.207

9.  PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.

Authors:  Yingze Wei; Danyang Liu; Xiaoxia Jin; Pan Gao; Qingying Wang; Jiawen Zhang; Nong Zhang
Journal:  Cancer Med       Date:  2016-10-18       Impact factor: 4.452

Review 10.  The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.

Authors:  Qingyu Zhang; Nadine Ellen Madden; Alice Sze Tsai Wong; Billy Kwok Chong Chow; Leo Tsz On Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.